PIK3CA and adenocarcinoma: Although many articles have even reviewed papers investigating or summarizing the biological and clinical roles of mutated PIK3CA in cancer, the majority of these studies were conducted in adenocarcinoma rather than in squamous cell carcinoma (SCC).